Evaluation of a human T cell-targeted multi-epitope vaccine for Q fever in animal models of Coxiella burnetti immunity. This paper is the result of a collaboration with Epivax, Inc., the Oxford Vaccine Group, Colorado State University and VIC published in Frontiers in Immunology.
EpiVax and Massachusetts General Hospital Advance on T cell-Targeted Epitope Vaccine for Q Fever
